FDA
-
-
-
-
-
-
-
XORTX Announces Type D Meeting with FDA to be held May 1, 2023
-
-
-
-
-
-
-
XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
-
-
-
-
-
-
-
XORTX Receives Small and Medium Enterprise StatusĀ for the European Union
-
-
-
-
324,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

